Regueiro M - Search Results

1

Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease.

Qapaja T, Abu-Rumaileh M, Alsabbagh Alchirazi K, Gharaibeh A, Naser A, Hamid O, Alayan D, Regueiro M. Qapaja T, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2024 Nov 13:izae267. doi: 10.1093/ibd/izae267. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39536156

2

Increased prevalence of gout in patients with inflammatory bowel disease: A population-based study.

Hamid O, Alsabbagh Alchirazi K, Eltelbany A, Nanah R, Regueiro M. Hamid O, et al. Among authors: regueiro m. JGH Open. 2023 Sep 1;7(9):640-644. doi: 10.1002/jgh3.12963. eCollection 2023 Sep. JGH Open. 2023. PMID: 37744707 Free PMC article.

3

Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.

Bhat S, Click B, Regueiro M. Bhat S, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2024 May 2;30(5):829-843. doi: 10.1093/ibd/izad120. Inflamm Bowel Dis. 2024. PMID: 37450619 Review.

4

Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?

Tanner S, Katz J, Cominelli F, Regueiro M, Cooper G, Mansoor E. Tanner S, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2023 Jun 1;29(6):1005-1007. doi: 10.1093/ibd/izac202. Inflamm Bowel Dis. 2023. PMID: 36169397

5

Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study.

Keluth Chavan A, Jha P, Perez JA, Harper E, Sinh P, Cooper G, Katz J, Cominelli F, Regueiro M, Mansoor E. Keluth Chavan A, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2024 Sep 11:izae203. doi: 10.1093/ibd/izae203. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39259586

6

Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity.

Desai A, Khataniar H, Hashash JG, Farraye FA, Regueiro M, Kochhar GS. Desai A, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2024 Apr 20:izae090. doi: 10.1093/ibd/izae090. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38642103

7

Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy.

Alkhayyat M, Abureesh M, Gill A, Khoudari G, Abou Saleh M, Mansoor E, Regueiro M. Alkhayyat M, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2021 Jun 15;27(7):1052-1060. doi: 10.1093/ibd/izaa252. Inflamm Bowel Dis. 2021. PMID: 33051651

8

Trends and Outcomes of Acute Diverticulitis in Inflammatory Bowel Disease: A Propensity-matched National Study.

Garg R, Mohammed A, Singh A, Regueiro M, Click B. Garg R, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2022 Jan 5;28(1):48-53. doi: 10.1093/ibd/izab017. Inflamm Bowel Dis. 2022. PMID: 33528011

9

Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease.

Alkhayyat M, Abureesh M, Almomani A, Abou Saleh M, Zmaili M, El Ouali S, Mansoor E, Rubio-Tapia A, Regueiro M. Alkhayyat M, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2022 Mar 2;28(3):385-392. doi: 10.1093/ibd/izab084. Inflamm Bowel Dis. 2022. PMID: 34002219

10

Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.

Click B, Lopez R, Arrigain S, Schold J, Regueiro M, Rizk M. Click B, et al. Among authors: regueiro m. Inflamm Bowel Dis. 2020 Jul 17;26(8):1268-1275. doi: 10.1093/ibd/izz256. Inflamm Bowel Dis. 2020. PMID: 31671186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters